RNA Supply Chain Resources

1. Reducing Lead Time, Delivering >99.5% OTIF 1/23/2024

   Explore the stocking solution offered to a mid-sized CDMO in need of a high volume of safety stock inventory to support their customer portfolio growth.

2. The Role Of CRISPR Cas9 Plasmids In Gene-Editing 12/12/2023

   Plasmids are crucial for CRISPR-Cas9 gene-editing technology, and their role in CRISPR is expected to evolve with ongoing research.

3. Revolutionizing Patient-Centric Supply Chains To Improve Vaccine Access 3/1/2023

   Transparent collaboration and innovation are essential to establishing an infrastructure that supports more agile business models and empowers widespread vaccine access.

4. mRNA Vaccine Development: Planning, Workflow, Supply Chain Success 5/17/2022

   A review of insights derived from the development of mRNA-based COVID-19 vaccines and how they can be applied to accelerate progress in the manufacture of vaccines and therapeutics moving forward.

5. Transitioning From Using RUO To cGMP Chemicals For Clinical Trials 10/17/2023

   Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.

6. Mastering mRNA Manufacturing: A Focus on Raw Materials & Supply Assurance 10/23/2024

   Rapid advancements in mRNA-based therapeutic development have underscored the role of raw material quality and supply chain management in ensuring their successful production.

7. Understanding The Hidden Value Of Quality 6/26/2023

   Costs of poor quality (COPQ) cannot be overstated. Review the statistics that prove how costly it can be to avoid resolving quality issues in your processes and supply chain.

8. Novel Lipid Nanoparticle Delivery Reagent And Manufacturing Workflow 4/18/2022

   We aim to highlight that commercially available LNP reagent mix, GenVoy-ILM, is an accessible and easy-to-use LNP formulation that allows for rapid preclinical development of RNA vaccines.

9. Demystifying CRISPR gRNA Chemical Modifications 10/28/2024

   Chemical modifications on CRISPR gRNAs enhance stability, editing efficiency, and reduce immune responses, enabling in vivo applications and clinical success.

10. Enabling CDMOs To Focus On Core Priorities 4/26/2024

    Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.